Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Introduction Obese and type 2 diabetic (T2DM) adolescents present with reduced insulin-stimulated glucose disposal and elevated intramyocellular lipids (IMCL) indicating comparable muscular insulin resistance and increased flux of free fatty acids (FFA) as in adult patients. In humans, the causal relationships between obesity and insulin resistance were examined in detail over the last years.Methods The impact of genetic factors was analyzed in young nonobese nondiabetic first-degree relatives of T2DM (REL-DM), whereas environmental factors were tested by challenging humans without genetic T2DM risk with lipid infusions or high-fat diets.Results REL-DM exhibit defects in mitochondrial oxidation and phosphorylation. Increased FFA availability results in accumulation of intramyocellular fatty acyl-CoA (FA-CoA) inducing a series of alterations: (i) inhibition of insulin signaling, (ii) reduction of insulin-(in)dependent glucose transport/phosphorylation, (iii) decreased insulin-stimulated glycogen synthesis, (iv) impaired insulin-stimulated oxidative phosphorylation (ATP synthesis), (v) accumulation of ectopic triglycerides (IMCL), (vi) reduced expression of peroxisome proliferator activated receptor gamma (PPARgamma) coactivator-1 (PGC-1) and PGC-1-controlled genes involved in mitochondrial biogenesis and oxidative phosphorylation and possibly also (vii) initiation of inflammatory processes by activation of PKC and nuclear factor-kappaB and decreased expression of matrix metalloproteinases (MMPs).Conclusions The abnormalities could lead to a vicious cycle in which mitochondrial dysfunction, elevation of intramycellular lipids, impaired lipid oxidation and insulin resistance amplify each other. This is similar to the adaptive changes to fasting, which prevent energy loss during excessive FFA availability. The sequence of events may start with mitochondrial dysfunction in genetic insulin resistance and with increased intramyocellular lipids in environmental insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These and other studies led to the proposal that insulin resistant humans have faulty muscle mitochondria and intrinsic deficiencies in oxidative metabolism that impinge on insulin signaling by diverting fatty acids away from oxidation and toward production of diacylglycerols and other toxic lipid species (Lowell and Shulman, 2005; Roden, 2005).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Roden, 2005
In the citing paper
“suggest that this mitochondrial defect contributes to the increased intramyocellar fat content.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [16]
In the citing paper
“Recent studies have reported a mitochondrial defect in oxidative phosphorylation in skeletal muscle in variety of insulin resistant states.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [16]
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Obesity and the Metabolic Syndrome in Children and Adolescents
Weiss, R., Dziura, J., Burgert, T. S., Tamborlane, W. V., Taksali, S. E., Yeckel, C. W., Allen, K., Lopes, M., Savoye, M., Morrison, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031049 · Cited by 3,459
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 1×
“The relative roles of lipid delivery and intramyocellular metabolism were studied in a similarly selected group of lean REL-DM featuring 60p lower insulin sensitivity and 80p higher IMCL in soleus muscle compared with their age- and body fat mass-matched control group”
BackgroundMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 1×
“The relationship between insulin resistance, intracellular lipids and mitochondrial metabolism was recently studied by combining1Hs6,62H 2 rglucose and l5nglycerol in lean insulin-resistant elderly humans”
BackgroundPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952 · cited 1×
“28 and that expression of PGC-1 and PGC-1 controlled mitochondrial genes involved in electron transport, oxidative phosphorylation including ATP synthase is impaired in overt T2DM strengthens this hypothesis”
BackgroundRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity
Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., Savoye, M., Rieger, V., Taksali, S., Barbetta, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012578 · Cited by 1,709 · cited 1×
“Impaired glucose tolerance (IGT) upon oral glucose challenge is present in 20–25p of obese youngsters and defines the prediabetic state preceding overt diabetes, which occurs in ∼4p of obese adolescents”
BackgroundMechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539 · cited 1×
“This was followed by reductions in glucose oxidation by 40p after 2 h, insulin-stimulated glucose disposal by 46p and muscular glycogen synthesis by 50p starting at 3 h of lipidsheparin infusion”
MethodSelf-citationItani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390 · cited 1×
“22 After 6 h of lipid infusion, the 43p reduction in whole body glucose disposal was accompanied by a three-fold increase in diacylglycerol (DAG), four-fold increase in protein kinase C (PKC) activity with recruitment of the β and δ isoforms of PKC to the cell membrane as well as a 70p decrease of I κ B- α , an inhibi…”
BackgroundDresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311 · cited 1×
“17 and reduce the intramyocellular free glucose concentration suggesting that FFA primarily inhibit glucose transport”
BackgroundKrssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S. M., Rothman, D. L., Shulman, G. I., & Roden, M. (1999) · Diabetologia · doi:10.1007/s001250051123 · Cited by 1,264 · cited 1×
“4 Such positive relationship between insulin resistance and IMCL has been demonstrated in healthy nondiabetic”
BackgroundSelf-citationFuel selection in human skeletal muscle in insulin resistance: a reexamination.
Kelley, D. E., & Mandarino, L. J. (2000) · Diabetes · doi:10.2337/diabetes.49.5.677 · Cited by 1,017 · cited 1×
“The findings that lipid oxidation and FFA utilization are decreased in insulin-resistant state”
BackgroundDeficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
Ritov, V. B., Menshikova, E. V., He, J., Ferrell, R. E., Goodpaster, B. H., & Kelley, D. E. (2005) · Diabetes · doi:10.2337/diabetes.54.1.8 · Cited by 887 · cited 1×
“26 T2DM, but also nondiabetic obese humans feature marked abnormalities in mitochondrial form, distribution and function”
BackgroundPerseghin, G., Scifo, P., De Cobelli, F., Pagliato, E., Battezzati, A., Arcelloni, C., Vanzulli, A., Testolin, G., Pozza, G., Del Maschio, A., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1600 · Cited by 877
Perseghin, G., Price, T. B., Petersen, K. F., Roden, M., Cline, G. W., Gerow, K., Rothman, D. L., & Shulman, G. I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351804 · Cited by 699 · cited 1×
“8 These defects are already present in young nonobese nondiabetic REL-DM and can be only partly normalized by exercise training”
BackgroundSelf-citationSparks, L. M., Xie, H., Koza, R. A., Mynatt, R., Hulver, M. W., Bray, G. A., & Smith, S. R. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1926 · Cited by 629 · cited 1×
“24 Likewise a high-fat isocaloric diet for 3 days resulted in reduction of the expression of OXPHOS genes belonging to mitochondrial complex I, II and one mitochondrial carrier protein as well as reduction by 20 and 25p of PGC-1 α and PGC-1 β”
MethodBoden, G., Lebed, B., Schatz, M., Homko, C., & Lemieux, S. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1612 · Cited by 597 · cited 1×
“18 Under these conditions, IMCL increase after 4 h of plasma FFA elevation”
BackgroundHow Obesity Causes Diabetes: Not a Tall Tale
Lazar, M. A. (2005) · Science · doi:10.1126/science.1104342 · Cited by 568 · cited 1×
“Of note, plasma concentrations of adipocyte-derived cytokines such as interleukin-6, tumor necrosis factor- α , resistin and adiponectin, which have been implicated in the pathogenesis of insulin resistance”
BackgroundPrevalence and Trends of a Metabolic Syndrome Phenotype Among U.S. Adolescents, 1999–2000
Duncan, G. E., Li, S. M., & Zhou, X.-H. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2438 · Cited by 500 · cited 1×
“4p between 1988 and 2000 in the National Health and Nutrition Surveys (NHANES) and is now present in ∼32p of overweight adolescent”
BackgroundWeiss, R., Dufour, S., Taksali, S. E., Tamborlane, W. V., Petersen, K. F., Bonadonna, R. C., Boselli, L., Barbetta, G., Allen, K., Rife, F., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14364-4 · Cited by 499 · cited 1×
“This prediabetic state is further characterized by slightly higher visceral fat mass, accumulation of fat within skeletal muscle cells (intramyocellular lipids, IMCL) both of which negatively correlate with insulin sensitivity and glucose tolerance status”
BackgroundStump, C. S., Short, K. R., Bigelow, M. L., Schimke, J. M., & Nair, K. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332551100 · Cited by 477 · cited 1×
“20 Impairment of insulin-stimulated ATP production was also demonstrated in vastus lateralis muscle from overt T2DM”
BackgroundDose-Response Effect of Elevated Plasma Free Fatty Acid on Insulin Signaling
Belfort, R., Mandarino, L., Kashyap, S., Wirfel, K., Pratipanawatr, T., Berria, R., DeFronzo, R. A., & Cusi, K. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1640 · Cited by 404 · cited 1×
“18 When insulin-stimulated glucose disposal was reduced by 34p after 4 h of lipid infusion, FFA elevation concentration-dependently inhibited by 53–55p not only tyrosine phosphorylation of the insulin receptor and IRS-1, IRS1-PI3 K activity but also serine phosphorylation of Akt, which is controlled by ceramide and ac…”
BackgroundTremblay, F., Krebs, M., Dombrowski, L., Brehm, A., Bernroider, E., Roth, E., Nowotny, P., Waldhäusl, W., Marette, A., & Roden, M. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2674 · Cited by 370
Self-citationEk, J., Andersen, G., Urhammer, S. A., Gæde, P. H., Drivsholm, T., Borch-Johnsen, K., Hansen, T., & Pedersen, O. (2001) · Diabetologia · doi:10.1007/s001250100032 · Cited by 293
Richardson, D. K., Kashyap, S., Bajaj, M., Cusi, K., Mandarino, S. J., Finlayson, J., DeFronzo, R. A., Jenkinson, C. P., & Mandarino, L. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408985200 · Cited by 259 · cited 1×
“A rise of plasma FFA for 48 h decreased the expression PGC-1 and a series of nuclear encoded mitochondrial genes”
BackgroundIncreased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle
Brehm, A., Krssak, M., Schmid, A. I., Nowotny, P., Waldhäusl, W., & Roden, M. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-1286 · Cited by 239 · cited 1×
“19 Recently, we demonstrated that the FFA-induced 46p decrease in whole body glucose metabolism and 70p lower rise of intramyocellular glucose-6-phosphate occurs without significant changes in IMCL, but is associated with 24p lower mitochondrial phosphorylation assessed with noninvasive saturation transfer31P MRS in s…”
BackgroundSelf-citationHow Free Fatty Acids Inhibit Glucose Utilization in Human Skeletal Muscle
Roden, M. (2004) · Physiology · doi:10.1152/nips.01459.2003 · Cited by 193 · cited 1×
“Nevertheless, plasma FFA concentrations are generally increased in insulin-resistant humans such as obese, REL-T2DM and T2DM and correlate with the degree of hyperglycemia, skeletal muscle insulin resistance and the risk of developing T2DM”
BackgroundSelf-citationRapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans.
Roden, M., Krssak, M., Stingl, H., Gruber, S., Hofer, A., Fürnsinn, C., Moser, E., & Waldhäusl, W. (1999) · Diabetes · doi:10.2337/diabetes.48.2.358 · Cited by 192
Self-citationKautzky-Willer, A., Krssak, M., Winzer, C., Pacini, G., Tura, A., Farhan, S., Wagner, O., Brabant, G., Horn, R., Stingl, H., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.244 · Cited by 150
Self-citationKrebs, M., Krššák, M., Nowotny, P., Weghuber, D., Gruber, S., Mlynárik, V., Bischof, M. G., Stingl, H., Fürnsinn, C., Waldhäusl, W. K., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7488 · Cited by 92
Nutrient sensor links obesity with diabetes risk
Patti, M., & Kahn, B. B. (2004) · Nature Medicine · doi:10.1038/nm1004-1049 · Cited by 70 · cited 1×
“30 which upon activation by amino acids can also directly induce insulin resistance by serine phosphorylation of IRS-1 in human skeletal muscle”
BackgroundKrebs, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.5.2153 · Cited by 53
Skeletal muscle phosphatidylcholine fatty acids and insulin sensitivity in normal humans
Clore, J. N., Li, J., Gill, R., Gupta, S., Spencer, R., Azzam, A., Zuelzer, W., Rizzo, W. B., & Blackard, W. G. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.4.e665 · Cited by 52
Roden, M. (2001) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200107000-00003 · Cited by 33
Self-citation
Cited by
Pathogenesis of insulin resistance in skeletal muscle
Abdul-Ghani, M. A., & DeFronzo, R. A. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/476279 · Cited by 670
“The recent studies have reported the existence of a defect in mitochondrial oxidative phosphorylation in skeletal muscle in insulin resistance states [16–20] and suggest that this mitochondrial defect contributes to the increased intramyocellar fat content.”
BackgroundTXNIP regulates peripheral glucose metabolism in humans
Parikh, H., Carlsson, E., Chutkow, W. A., Johansson, L. E., Storgaard, H., Poulsen, P., Saxena, R., Ladd, C., Schulze, P. C., Mazzini, M. J., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040158 · Cited by 495
“Although obesity is the most important risk factor for insulin resistance in the prediabetic state [5], other factors such as the toxic effects of elevated glucose (glucotoxicity) and lipids (lipotoxicity) also contribute to insulin resistance with progression of the disease [6].”
BackgroundMeex, R. C. R., Schrauwen-Hinderling, V. B., Moonen-Kornips, E., Schaart, G., Mensink, M., Phielix, E., van de Weijer, T., Sels, J.-P., Schrauwen, P., & Hesselink, M. K. C. (2010) · Diabetes · doi:10.2337/db09-1322 · Cited by 355
“The combination of increased intramyocellular lipid (IMCL) and a low oxidative capacity are key features in the development of muscular insulin resistance (1-3).”
BackgroundLipid-Induced Mitochondrial Stress and Insulin Action in Muscle
Muoio, D. M., & Neufer, P. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.010 · Cited by 343
“These and other studies led to the proposal that insulin resistant humans have faulty muscle mitochondria and intrinsic deficiencies in oxidative metabolism that impinge on insulin signaling by diverting fatty acids away from oxidation and toward production of diacylglycerols and other toxic lipid species (Lowell and…”
BackgroundCorrea-de-Araujo, R., Harris-Love, M. O., Miljkovic, I., Fragala, M. S., Anthony, B. W., & Manini, T. M. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00087 · Cited by 268
“Impaired skeletal muscle mitochondrial function, which directs fatty acids toward storage as opposed to oxidation, may also contribute to agingrelated increases in skeletal muscle fat accumulation (Roden, 2005; Mathieu et al., 2010).”
Background
Metadata
- Authors
- Roden, M.
- Affiliations
- Hanusch Hospital (AT)
- Corresponding author
- Roden, M
- ORCID
- Roden, M
- Venue
- International Journal of Obesity
- Published
- 2005-09
- Volume
- 29
- Issue
- S2
- Pages
- S111-S115
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W1999266780
- Cited by
- 149
- References
- 34
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 5 · 2022: 1 · 2021: 5 · 2020: 6 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 8 · 2015: 8 · 2014: 12 · 2013: 11 · 2012: 12
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, muscle triglycerides, intramyocellular lipid, mitochondrial dysfunction, insulin resistance, free fatty acids, fatty acyl-CoA, insulin signaling, glucose transport, glycogen synthesis, oxidative phosphorylation, PGC-1, mitochondrial biogenesis, obesity, adolescents, first-degree relatives of diabetics, high-fat diet, lipid infusion, inflammation, matrix metalloproteinases, nuclear factor-kappaB, protein kinase C
- MeSH terms
- Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Dietary Fats, Humans, Insulin Resistance, Lipids, Mitochondria, Muscle, Triglycerides, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.